Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study

BACKGROUND/AIMS: Prospective data on switching anti-vascular endothelial growth factors in patients with neovascular age-related macular degeneration (nAMD) who have previously shown no/partial response are limited. This prospective study assessed the effect of switching from aflibercept to ranibizu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gale, Richard P, Pearce, Ian, Eter, Nicole, Ghanchi, Faruque, Holz, Frank G, Schmitz-Valckenberg, Steffen, Balaskas, Konstantinos, Burton, Ben J L, Downes, Susan M, Eleftheriadis, Haralabos, George, Sheena, Gilmour, David, Hamilton, Robin, Lotery, Andrew J, Patel, Nishal, Prakash, Priya, Santiago, Cynthia, Thomas, Saju, Varma, Deepali, Walters, Gavin, Williams, Michael, Wolf, Armin, Zakri, Rosina H, Igwe, Franklin, Ayan, Filis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147176/
https://www.ncbi.nlm.nih.gov/pubmed/31383649
http://dx.doi.org/10.1136/bjophthalmol-2019-314251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147176/
https://www.ncbi.nlm.nih.gov/pubmed/31383649
http://dx.doi.org/10.1136/bjophthalmol-2019-314251

Ejemplares similares